TATAYANA MALTSEVA: Open Payments
NPI 1134502578 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 19 payments from 8 companies in 2025. Trend: 2023 $923 · 2024 $1,049 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $300 |
| Teva Pharmaceuticals USA, Inc. | 5 | $276 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Alkermes, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Abbott Laboratories | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: CAPLYTA, UZEDY, AUSTEDO XR, COBENFY, ARISTADA, VRAYLAR, INVEGA SUSTENNA, EPIC.
Industry payments across FL — which companies pay providers there.
